Health
CanSino to start Phase III trial of COVID-19 vaccine in Saudi – Marketscreener.com
Saudi Arabia will soon begin Phase
III clinical trials on around 5,000 people for a COVID-19
vaccine developed by China’s CanSino Biologics Inc, a
Saudi health ministry spokesman said on Sunday.
… | August 9, 2020
DUBAI, Aug 9 (Reuters) – Saudi Arabia will soon begin Phase
III clinical trials on around 5,000 people for a COVID-19
vaccine developed by China’s CanSino Biologics Inc, a
Saudi health ministry spokesman said on Sunday.
Last month, CanSino’s co-founder said the company was in
talks with Russia, Brazil, Chile and Saudi Arabia to launch a
Phase III trial of the vaccine candidate, Ad5-nCOV.
The vaccine uses a harmless cold virus known as adenovirus
type-5 (Ad5) to carry genetic material fro…
-
General20 hours agoGymnastics club in Berwick shuts down following child safety complaint
-
Noosa News23 hours agoSanta drops in for carols
-
General14 hours agoAshes engulfed by fresh DRS controversy as TV umpire gives Jamie Smith out despite RTS ‘murmur’
-
General22 hours agoTwo dead after separate road accidents in regional New South Wales